New

Neurological Disorder Diagnostics Market

2021

Neurological Disorder Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Imaging, In Vitro Diagnostics); Diseases Indication (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, Paraproteinemic Neuropathies, Other Disease Indication); End-User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers)

| Report Code: TIPHE100001432 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Neurological Disorder Diagnostics Market 2028 By Technology, Diseases Indication, End-User | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW

Diagnostic tests are vital tools that help rule out or confirm the presence of neurological disorders among individuals facing specific symptoms. The advances in brain monitoring lead to living visualization of brain interior and live brain functions. This technology helps neurologists to diagnose neurological diseases with accuracy. Two techniques majorly accomplish the investigation of neurological disorders as imaging and in vitro diagnostics.

MARKET SCOPE

The "Global Neurological Disorder Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the neurological disorder diagnostics market with detailed market segmentation by technology, diseases indication, end user, and geography. The report provides key statistics on the market status of the leading neurological disorder diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  • Based on technology, the global neurological disorder diagnostics market is segmented into imaging, in vitro diagnostics.
  • Based on diseases indication, the market is bifurcated into genetic neurological disorders, immunological neurological disorders, paraneoplastic syndrome, paraproteinemic neuropathies, other disease indication.
  • Based on end user, the market is bifurcated into hospitals & clinics, diagnostic centers, ambulatory care centers.

MARKET DYNAMICS

Drivers

  • Increasing prevalence of cerebral and neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis among others
  • Rapid growth in the geriatric population across the globe
  • New market players are entering the market owing to the technological advancement of products.

Restraints

  • High costs of the imaging devices

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The neurological disorder diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the neurological disorder diagnostics market in these regions.

IMPACT OF COVID-19 ON NEUROLOGICAL DISORDER DIAGNOSTICS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the neurological disorder diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from neurological disorder diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for neurological disorder diagnostics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the neurological disorder diagnostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • General Electric
  • Esaote SpA
  • Neurologica Corp.
  • Lifelines Neuro Company, LLC
  • Advanced Brain Monitoring
  • Nihon Kohden Corporation
  • Thermo Fisher Scientific, Inc.
  • Natus Medical Incorporated

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neurological Disorder Diagnostics Market - By Technology
1.3.2 Neurological Disorder Diagnostics Market - By Diseases Indication
1.3.3 Neurological Disorder Diagnostics Market - By End-User
1.3.4 Neurological Disorder Diagnostics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. NEUROLOGICAL DISORDER DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. NEUROLOGICAL DISORDER DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. IMAGING
7.3.1. Overview
7.3.2. Imaging Market Forecast and Analysis
7.4. IN VITRO DIAGNOSTICS
7.4.1. Overview
7.4.2. In Vitro Diagnostics Market Forecast and Analysis
8. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - DISEASES INDICATION
8.1. OVERVIEW
8.2. DISEASES INDICATION MARKET FORECASTS AND ANALYSIS
8.3. GENETIC NEUROLOGICAL DISORDERS
8.3.1. Overview
8.3.2. Genetic Neurological Disorders Market Forecast and Analysis
8.4. IMMUNOLOGICAL NEUROLOGICAL DISORDERS
8.4.1. Overview
8.4.2. Immunological Neurological Disorders Market Forecast and Analysis
8.5. PARANEOPLASTIC SYNDROME
8.5.1. Overview
8.5.2. Paraneoplastic Syndrome Market Forecast and Analysis
8.6. PARAPROTEINEMIC NEUROPATHIES
8.6.1. Overview
8.6.2. Paraproteinemic Neuropathies Market Forecast and Analysis
8.7. OTHER DISEASE INDICATION
8.7.1. Overview
8.7.2. Other Disease Indication Market Forecast and Analysis
9. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
9.1. OVERVIEW
9.2. END-USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND CLINICS
9.3.1. Overview
9.3.2. Hospitals and Clinics Market Forecast and Analysis
9.4. DIAGNOSTIC CENTERS
9.4.1. Overview
9.4.2. Diagnostic Centers Market Forecast and Analysis
9.5. AMBULATORY CARE CENTERS
9.5.1. Overview
9.5.2. Ambulatory Care Centers Market Forecast and Analysis
10. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Neurological Disorder Diagnostics Market Overview
10.1.2 North America Neurological Disorder Diagnostics Market Forecasts and Analysis
10.1.3 North America Neurological Disorder Diagnostics Market Forecasts and Analysis - By Technology
10.1.4 North America Neurological Disorder Diagnostics Market Forecasts and Analysis - By Diseases Indication
10.1.5 North America Neurological Disorder Diagnostics Market Forecasts and Analysis - By End-User
10.1.6 North America Neurological Disorder Diagnostics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Neurological Disorder Diagnostics Market
10.1.6.1.1 United States Neurological Disorder Diagnostics Market by Technology
10.1.6.1.2 United States Neurological Disorder Diagnostics Market by Diseases Indication
10.1.6.1.3 United States Neurological Disorder Diagnostics Market by End-User
10.1.6.2 Canada Neurological Disorder Diagnostics Market
10.1.6.2.1 Canada Neurological Disorder Diagnostics Market by Technology
10.1.6.2.2 Canada Neurological Disorder Diagnostics Market by Diseases Indication
10.1.6.2.3 Canada Neurological Disorder Diagnostics Market by End-User
10.1.6.3 Mexico Neurological Disorder Diagnostics Market
10.1.6.3.1 Mexico Neurological Disorder Diagnostics Market by Technology
10.1.6.3.2 Mexico Neurological Disorder Diagnostics Market by Diseases Indication
10.1.6.3.3 Mexico Neurological Disorder Diagnostics Market by End-User
10.2. EUROPE
10.2.1 Europe Neurological Disorder Diagnostics Market Overview
10.2.2 Europe Neurological Disorder Diagnostics Market Forecasts and Analysis
10.2.3 Europe Neurological Disorder Diagnostics Market Forecasts and Analysis - By Technology
10.2.4 Europe Neurological Disorder Diagnostics Market Forecasts and Analysis - By Diseases Indication
10.2.5 Europe Neurological Disorder Diagnostics Market Forecasts and Analysis - By End-User
10.2.6 Europe Neurological Disorder Diagnostics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Neurological Disorder Diagnostics Market
10.2.6.1.1 Germany Neurological Disorder Diagnostics Market by Technology
10.2.6.1.2 Germany Neurological Disorder Diagnostics Market by Diseases Indication
10.2.6.1.3 Germany Neurological Disorder Diagnostics Market by End-User
10.2.6.2 France Neurological Disorder Diagnostics Market
10.2.6.2.1 France Neurological Disorder Diagnostics Market by Technology
10.2.6.2.2 France Neurological Disorder Diagnostics Market by Diseases Indication
10.2.6.2.3 France Neurological Disorder Diagnostics Market by End-User
10.2.6.3 Italy Neurological Disorder Diagnostics Market
10.2.6.3.1 Italy Neurological Disorder Diagnostics Market by Technology
10.2.6.3.2 Italy Neurological Disorder Diagnostics Market by Diseases Indication
10.2.6.3.3 Italy Neurological Disorder Diagnostics Market by End-User
10.2.6.4 Spain Neurological Disorder Diagnostics Market
10.2.6.4.1 Spain Neurological Disorder Diagnostics Market by Technology
10.2.6.4.2 Spain Neurological Disorder Diagnostics Market by Diseases Indication
10.2.6.4.3 Spain Neurological Disorder Diagnostics Market by End-User
10.2.6.5 United Kingdom Neurological Disorder Diagnostics Market
10.2.6.5.1 United Kingdom Neurological Disorder Diagnostics Market by Technology
10.2.6.5.2 United Kingdom Neurological Disorder Diagnostics Market by Diseases Indication
10.2.6.5.3 United Kingdom Neurological Disorder Diagnostics Market by End-User
10.2.6.6 Rest of Europe Neurological Disorder Diagnostics Market
10.2.6.6.1 Rest of Europe Neurological Disorder Diagnostics Market by Technology
10.2.6.6.2 Rest of Europe Neurological Disorder Diagnostics Market by Diseases Indication
10.2.6.6.3 Rest of Europe Neurological Disorder Diagnostics Market by End-User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Neurological Disorder Diagnostics Market Overview
10.3.2 Asia-Pacific Neurological Disorder Diagnostics Market Forecasts and Analysis
10.3.3 Asia-Pacific Neurological Disorder Diagnostics Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Neurological Disorder Diagnostics Market Forecasts and Analysis - By Diseases Indication
10.3.5 Asia-Pacific Neurological Disorder Diagnostics Market Forecasts and Analysis - By End-User
10.3.6 Asia-Pacific Neurological Disorder Diagnostics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Neurological Disorder Diagnostics Market
10.3.6.1.1 Australia Neurological Disorder Diagnostics Market by Technology
10.3.6.1.2 Australia Neurological Disorder Diagnostics Market by Diseases Indication
10.3.6.1.3 Australia Neurological Disorder Diagnostics Market by End-User
10.3.6.2 China Neurological Disorder Diagnostics Market
10.3.6.2.1 China Neurological Disorder Diagnostics Market by Technology
10.3.6.2.2 China Neurological Disorder Diagnostics Market by Diseases Indication
10.3.6.2.3 China Neurological Disorder Diagnostics Market by End-User
10.3.6.3 India Neurological Disorder Diagnostics Market
10.3.6.3.1 India Neurological Disorder Diagnostics Market by Technology
10.3.6.3.2 India Neurological Disorder Diagnostics Market by Diseases Indication
10.3.6.3.3 India Neurological Disorder Diagnostics Market by End-User
10.3.6.4 Japan Neurological Disorder Diagnostics Market
10.3.6.4.1 Japan Neurological Disorder Diagnostics Market by Technology
10.3.6.4.2 Japan Neurological Disorder Diagnostics Market by Diseases Indication
10.3.6.4.3 Japan Neurological Disorder Diagnostics Market by End-User
10.3.6.5 South Korea Neurological Disorder Diagnostics Market
10.3.6.5.1 South Korea Neurological Disorder Diagnostics Market by Technology
10.3.6.5.2 South Korea Neurological Disorder Diagnostics Market by Diseases Indication
10.3.6.5.3 South Korea Neurological Disorder Diagnostics Market by End-User
10.3.6.6 Rest of Asia-Pacific Neurological Disorder Diagnostics Market
10.3.6.6.1 Rest of Asia-Pacific Neurological Disorder Diagnostics Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Neurological Disorder Diagnostics Market by Diseases Indication
10.3.6.6.3 Rest of Asia-Pacific Neurological Disorder Diagnostics Market by End-User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Neurological Disorder Diagnostics Market Overview
10.4.2 Middle East and Africa Neurological Disorder Diagnostics Market Forecasts and Analysis
10.4.3 Middle East and Africa Neurological Disorder Diagnostics Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Neurological Disorder Diagnostics Market Forecasts and Analysis - By Diseases Indication
10.4.5 Middle East and Africa Neurological Disorder Diagnostics Market Forecasts and Analysis - By End-User
10.4.6 Middle East and Africa Neurological Disorder Diagnostics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Neurological Disorder Diagnostics Market
10.4.6.1.1 South Africa Neurological Disorder Diagnostics Market by Technology
10.4.6.1.2 South Africa Neurological Disorder Diagnostics Market by Diseases Indication
10.4.6.1.3 South Africa Neurological Disorder Diagnostics Market by End-User
10.4.6.2 Saudi Arabia Neurological Disorder Diagnostics Market
10.4.6.2.1 Saudi Arabia Neurological Disorder Diagnostics Market by Technology
10.4.6.2.2 Saudi Arabia Neurological Disorder Diagnostics Market by Diseases Indication
10.4.6.2.3 Saudi Arabia Neurological Disorder Diagnostics Market by End-User
10.4.6.3 U.A.E Neurological Disorder Diagnostics Market
10.4.6.3.1 U.A.E Neurological Disorder Diagnostics Market by Technology
10.4.6.3.2 U.A.E Neurological Disorder Diagnostics Market by Diseases Indication
10.4.6.3.3 U.A.E Neurological Disorder Diagnostics Market by End-User
10.4.6.4 Rest of Middle East and Africa Neurological Disorder Diagnostics Market
10.4.6.4.1 Rest of Middle East and Africa Neurological Disorder Diagnostics Market by Technology
10.4.6.4.2 Rest of Middle East and Africa Neurological Disorder Diagnostics Market by Diseases Indication
10.4.6.4.3 Rest of Middle East and Africa Neurological Disorder Diagnostics Market by End-User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Neurological Disorder Diagnostics Market Overview
10.5.2 South and Central America Neurological Disorder Diagnostics Market Forecasts and Analysis
10.5.3 South and Central America Neurological Disorder Diagnostics Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Neurological Disorder Diagnostics Market Forecasts and Analysis - By Diseases Indication
10.5.5 South and Central America Neurological Disorder Diagnostics Market Forecasts and Analysis - By End-User
10.5.6 South and Central America Neurological Disorder Diagnostics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Neurological Disorder Diagnostics Market
10.5.6.1.1 Brazil Neurological Disorder Diagnostics Market by Technology
10.5.6.1.2 Brazil Neurological Disorder Diagnostics Market by Diseases Indication
10.5.6.1.3 Brazil Neurological Disorder Diagnostics Market by End-User
10.5.6.2 Argentina Neurological Disorder Diagnostics Market
10.5.6.2.1 Argentina Neurological Disorder Diagnostics Market by Technology
10.5.6.2.2 Argentina Neurological Disorder Diagnostics Market by Diseases Indication
10.5.6.2.3 Argentina Neurological Disorder Diagnostics Market by End-User
10.5.6.3 Rest of South and Central America Neurological Disorder Diagnostics Market
10.5.6.3.1 Rest of South and Central America Neurological Disorder Diagnostics Market by Technology
10.5.6.3.2 Rest of South and Central America Neurological Disorder Diagnostics Market by Diseases Indication
10.5.6.3.3 Rest of South and Central America Neurological Disorder Diagnostics Market by End-User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NEUROLOGICAL DISORDER DIAGNOSTICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1. SIEMENS HEALTHINEERS
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. KONINKLIJKE PHILIPS N.V
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. GENERAL ELECTRIC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ESAOTE SPA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NEUROLOGICA CORP.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. LIFELINES NEURO COMPANY, LLC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ADVANCED BRAIN MONITORING
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. NIHON KOHDEN CORPORATION
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. THERMO FISHER SCIENTIFIC, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. NATUS MEDICAL INCORPORATED
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS

The List of Companies

1. Siemens Healthineers
2. Koninklijke Philips N.V.
3. General Electric
4. Esaote SpA
5. Neurologica Corp.
6. Lifelines Neuro Company, LLC
7. Advanced Brain Monitoring
8. Nihon Kohden Corporation
9. Thermo Fisher Scientific, Inc.
10. Natus Medical Incorporated
11. Canon Medical Systems Corporation
12. Masimo Corporation
13. York Instruments Ltd.
14. Neusoft Medical Systems
15. ECTRON

TIPHE100001432
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.